A longitudinal analysis of SLE patients treated with rituximab (anti-CD20) : factors associated with B lymphocyte recovery
Identifying factors associated with B lymphocyte depletion and recovery may aid the development of individualized treatment regimens, optimizing therapy for patients with autoimmune disease. In this study, 12 patients with active SLE were monitored at baseline and monthly following treatment with ri...
Ausführliche Beschreibung
Bibliographische Detailangaben
| Veröffentlicht in: | Clinical immunology (Orlando, Fla.). - 1999. - 126(2008), 3 vom: 01. März, Seite 282-90
|
|---|
| 1. Verfasser: |
Sutter, Jennifer A
(VerfasserIn) |
|---|
| Weitere Verfasser: |
Kwan-Morley, Jennifer,
Dunham, Jon,
Du, Yang-Zhu,
Kamoun, Malek,
Albert, Daniel,
Eisenberg, Robert A,
Luning Prak, Eline T |
|---|
| Format: | Online-Aufsatz
|
|---|
| Sprache: | English |
|---|
| Veröffentlicht: |
2008
|
|---|
| Zugriff auf das übergeordnete Werk: | Clinical immunology (Orlando, Fla.)
|
|---|
| Schlagworte: | Clinical Trial
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Antibodies, Monoclonal
Antibodies, Monoclonal, Murine-Derived
Antigens, CD20
Immunologic Factors
Rituximab
4F4X42SYQ6 |
|---|